Subretinal Rather Than Intravitreal Adeno-Associated Virus–Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage-Reference-Cited by-同舟云学术

Subretinal Rather Than Intravitreal Adeno-Associated Virus–Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage

Published:2021-04-08 Issue:4 Volume:62 Page:11
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Annamalai Balasubramaniam¹,Parsons Nathaniel¹,Nicholson Crystal¹,Obert Elisabeth¹,Jones Bryan²,Rohrer Bärbel¹³⁴

Affiliation:

1. Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States

2. Department of Ophthalmology, University of Utah, Salt Lake City, Utah, United States

3. Division of Research, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States

4. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Complement System as a Therapeutic Target in Retinal Disease;Medicina;2024-06-05

2. Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice;Journal of Clinical Medicine;2023-07-24

3. AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model;Investigative Opthalmology & Visual Science;2023-07-20

4. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model;Translational Vision Science & Technology;2023-07-18

5. Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration;Journal of Clinical Medicine;2023-04-14